Dr. Rebekah Danielle Sherlin-Chaplin, MD

Dr. Sherlin-Chaplin practices at CommonSpirit Memorial Hospital North Georgia (Closed) in Fort Oglethorpe, Georgia.

Dr. Sherlin-Chaplin's NPI, 1548795701, was assigned on April 25, 2017. Dr. Sherlin-Chaplin holds Tennessee license 61306.

Dr. Sherlin-Chaplin's primary practice is CommonSpirit Memorial Hospital North Georgia (Closed), at 100 Gross Crescent Cir, Fort Oglethorpe, GA 30742 in Catoosa County. The practice phone is (706) 858-2000.

Dr. Sherlin-Chaplin's primary practice is CommonSpirit Memorial Hospital North Georgia (Closed) in Fort Oglethorpe, Georgia. Dr. Sherlin-Chaplin is also affiliated with CommonSpirit - Memorial Hospital - Chattanooga. The medical group on file is Memorial Health Partners Foundation. Dmand AI also links Dr. Sherlin-Chaplin to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sherlin-Chaplin practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sherlin-Chaplin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sherlin-Chaplin is licensed in Tennessee.

CMS data shows 843 Medicare services from Dr. Sherlin-Chaplin across 5 procedure codes in 2024, for 308 Medicare patients. Medicare paid $72,471 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 308 Medicare patients who saw Dr. Sherlin-Chaplin in 2024. The largest group is 75 to 84, with 123 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sherlin-Chaplin's median patient age at 75, with 55% women.

In 2024, Dr. Sherlin-Chaplin wrote 431 Medicare Part D claims for 183 patients. 89% of them were for generic drugs. CMS names the drug for 203 of them, across 12 drugs with 11 or more claims each, at $6,507 in total drug cost. In 2023, CMS named 188 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Sherlin-Chaplin for performance year 2024, reported through an alternative payment model (APM). Dr. Sherlin-Chaplin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 20 general payments to Dr. Sherlin-Chaplin from 3 drug and device companies from 2020 to 2022. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $286.